Skip to main content
. 2020 Jun 12;13:5563–5574. doi: 10.2147/OTT.S249429

Table 2.

SNHG12 Expression and Clinicopathologic Features in 80 Cases of DLBCL

Variables Total (n=80) SNHG12, n (%) P-value
High Expression (n=40) Low Expression (n=40)
Age, year
 <60 39 21 (52.5) 18 (45.0) 0.502
 ≥60 41 19 (47.5) 22 (55.0)
Gender
 Male 40 24 (54.5) 16 (44.4) 0.369
 Female 40 20 (45.5) 20 (55.6)
B symptoms
 Absent 40 19 (57.6) 21 (44.7) 0.256
 Present 40 14 (42.4) 26 (55.3)
Stages
 I-II 45 16 (40.0) 29 (72.5) 0.003
 III-IV 35 24 (60.0) 11 (27.5)
Extra-nodal invasion
 Yes 49 30 (75.0) 19 (47.5) 0.012
 No 31 10 (25.0) 21 (52.5)
Serum LDH
 <300 39 14 (35.0) 25 (62.5) 0.014
 ≥300 41 26 (65.0) 15 (37.5)
IPI score
 0–2 31 14 (35.0) 17 (42.5) 0.491
 3–5 49 26 (65.0) 23 (57.5)

Note: P < 0.05 is showed in bold.

Abbreviations: DLBCL, diffuse large B-cell lymphoma; LDH, lactate dehydrogenase; IPI, International Prognostic Index.